|
Current issue
Archive
Online First
About the journal
Editorial board
Editorial office
Publisher
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
|
4/2021
vol. 20 abstract:
Review paper
Endometriosis and gynaecological cancers: molecular insights behind a complex machinery
Vaclav Vetvicka
1
,
Ludek Fiala
2
,
Simone Garzon
3
,
Giovanni Buzzaccarini
4
,
Milan Terzic
5, 6, 7
,
Antonio Simone Laganà
8
Menopause Rev 2021; 20(4): 201-206
Online publish date: 2021/12/06
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Endometriosis is described as the presence of both endometrial glandular and stromal cells outside the uterine cavity. A major characterization of this disease is ectopic implantation of endometrial cells with increased migration. It is one of the leading causes of morbidity among premenopausal women, with a prevalence of 10–16% of women of reproductive age. Despite over century of intensive research, none of the current treatment options represents a real cure. Based on the current knowledge, endometriosis, particularly its atypical version, is considered to be a transitional form from benign disease to tumour. However, the exact mechanisms of this conversion are still not fully established.
keywords:
endometriosis, cancer, ovarian cancer |